|
The form may be used to submit information about multiple drugs at the same time and there is no request at this time to submit a new notification if an issue resolves.
NTCA may follow-up with the submitter directly for additional details as needed, and NTCA will use this information to alert programs and partners of emerging situations, and to communicate about emerging situations with the FDA.
|